Brief: Sun Pharma Advanced Research Announces Positive Results From Phase 3 Trial For Glaucoma Treatment

Sun Pharma Advanced Research

14/05/2021 06:38

May 14 (Reuters) - Sun Pharma Advanced Research Co Ltd
 SPRC.NS :
    * ANNOUNCES POSITIVE TOP-LINE RESULTS FROM PHASE 3 TRIAL OF
PDP-716 FOR TREATING OPEN ANGLE GLAUCOMA/OCULAR HYPERTENSION
    * TRIAL MET PRE-SPECIFIED PRIMARY ENDPOINT

Source text for Eikon:  ID:nBSE6jD4B8 
Further company coverage:  SPRC.NS 

 ((Reuters.Briefs@thomsonreuters.com;))